186 related articles for article (PubMed ID: 21460383)
1. Tobacco and nicotine product testing.
Hatsukami DK; Biener L; Leischow SJ; Zeller MR
Nicotine Tob Res; 2012 Jan; 14(1):7-17. PubMed ID: 21460383
[TBL] [Abstract][Full Text] [Related]
2. Postmarketing surveillance for "modified-risk" tobacco products.
O'Connor RJ
Nicotine Tob Res; 2012 Jan; 14(1):29-42. PubMed ID: 21330282
[TBL] [Abstract][Full Text] [Related]
3. Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act.
Hecht SS
Nicotine Tob Res; 2012 Jan; 14(1):18-28. PubMed ID: 21324834
[TBL] [Abstract][Full Text] [Related]
4. Tobacco packaging and labeling policies under the U.S. Tobacco Control Act: research needs and priorities.
Hammond D
Nicotine Tob Res; 2012 Jan; 14(1):62-74. PubMed ID: 22039072
[TBL] [Abstract][Full Text] [Related]
5. Research priorities and infrastructure needs of the Family Smoking Prevention and Tobacco Control Act: science to inform FDA policy.
Leischow SJ; Zeller M; Backinger CL
Nicotine Tob Res; 2012 Jan; 14(1):1-6. PubMed ID: 22184581
[TBL] [Abstract][Full Text] [Related]
6. Smokers' reactions to FDA regulation of tobacco products: findings from the 2009 ITC United States survey.
Fix BV; O'Connor RJ; Fong GT; Borland R; Cummings KM; Hyland A
BMC Public Health; 2011 Dec; 11():941. PubMed ID: 22177316
[TBL] [Abstract][Full Text] [Related]
7. Permissive nicotine regulation as a complement to traditional tobacco control.
Sumner W
BMC Public Health; 2005 Feb; 5():18. PubMed ID: 15730554
[TBL] [Abstract][Full Text] [Related]
8. Nicotine reduction revisited: science and future directions.
Hatsukami DK; Perkins KA; Lesage MG; Ashley DL; Henningfield JE; Benowitz NL; Backinger CL; Zeller M
Tob Control; 2010 Oct; 19(5):e1-10. PubMed ID: 20876072
[TBL] [Abstract][Full Text] [Related]
9. No sisyphean task: how the FDA can regulate electronic cigarettes.
Paradise J
Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
[TBL] [Abstract][Full Text] [Related]
10. Toward a comprehensive policy on nicotine delivery products and harm reduction.
Solyst J
Food Drug Law J; 2012; 67(4):393-404, i. PubMed ID: 24640613
[TBL] [Abstract][Full Text] [Related]
11. Research gaps related to tobacco product marketing and sales in the Family Smoking Prevention and Tobacco Control Act.
Ribisl KM
Nicotine Tob Res; 2012 Jan; 14(1):43-53. PubMed ID: 21690316
[TBL] [Abstract][Full Text] [Related]
12. The importance of product definitions in US e-cigarette laws and regulations.
Lempert LK; Grana R; Glantz SA
Tob Control; 2016 Apr; 25(e1):e44-51. PubMed ID: 25512432
[TBL] [Abstract][Full Text] [Related]
13. Consortium on Methods Evaluating Tobacco: Research Tools to Inform US Food and Drug Administration Regulation of Snus.
Berman ML; Bickel WK; Harris AC; LeSage MG; O'Connor RJ; Stepanov I; Shields PG; Hatsukami DK
Nicotine Tob Res; 2018 Sep; 20(11):1292-1300. PubMed ID: 29059363
[TBL] [Abstract][Full Text] [Related]
14. Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations.
Vansickel A; Baxter S; Sherwood N; Kong M; Campbell L
Nicotine Tob Res; 2022 Feb; 24(3):295-305. PubMed ID: 34498698
[TBL] [Abstract][Full Text] [Related]
15. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
[TBL] [Abstract][Full Text] [Related]
16. Policy and health implications of using the U.S. Food and Drug Administration product design approach in reducing tobacco product risk.
Givel M
Curr Drug Abuse Rev; 2008 Jun; 1(2):135-41. PubMed ID: 19630712
[TBL] [Abstract][Full Text] [Related]
17. Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.
Henningfield JE; Hatsukami DK; Zeller M; Peters E
Drug Alcohol Depend; 2011 Jul; 116(1-3):1-7. PubMed ID: 21376479
[TBL] [Abstract][Full Text] [Related]
18. Research opportunities concerning youth and the Family Smoking Prevention and Tobacco Control Act.
DiFranza JR
Nicotine Tob Res; 2012 Jan; 14(1):54-61. PubMed ID: 21975309
[No Abstract] [Full Text] [Related]
19. [Harm reduction strategy in tobacco control].
Gorini G
Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
[TBL] [Abstract][Full Text] [Related]
20. Substantial Equivalence Standards in Tobacco Governance: Statutory Clarity and Regulatory Precedent for the FSPTCA.
Carpenter D; Connolly GN; Lempert LK
J Health Polit Policy Law; 2017 Aug; 42(4):607-644. PubMed ID: 27864349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
